Condition: Esophagus Adenocarcinoma · Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
The present clinical trial is a prospective, investigator-initiated, single-arm, open-label, multicenter phase II trial investigating whether a definite organ preservation therapy consisting of the combination of durvalumab with chemoradiation is an efficient and safe treatment option for early stage, cT1 and cT2N0, esophageal adenocarcinoma with indication for radical surgery.
This description comes directly from the study's public registry record.
Thorsten Götze, Prof. Dr. · +496976014187 · goetze.thorsten@khnw.de
Ulas Tenekeci, Dr. · +49 69 589978764 · tenekeci.ulas@ikf-khnw.de
Always discuss trial participation with your own doctor first.
| Klinikum St. Marien Kommunalunternehmen - Anstalt des öffentlichen Rechts der Stadt Amberg | Amberg, Germany | Recruiting |
| HELIOS Klinikum Bad Saarow | Bad Saarow, Germany | Recruiting |
| Charite Univeristätsmedizin Berlin | Berlin, Germany | Not Yet Recruiting |
| Universitätsklinikum Brandenburg an der Havel Medizinische Hochschule Brandenburg | Brandenburg an der Havel, Germany | Recruiting |
| Krankenhaus St. Joseph-Stift GmbH | Bremen, Germany | Recruiting |
| Klinikum Darmstadt GmbH | Darmstadt, Germany | Not Yet Recruiting |
| Kliniken Essen Mitte Klinik für Internistische Onkologie und Hämatologie | Essen, Germany | Recruiting |
| Institute of Clinical Cancer Research, University Cancer Center (UCT) Frankfurt Krankenhaus Nordwest | Frankfurt, Germany | Recruiting |
| Universitätsmedizin Göttingen | Göttingen, Germany | Recruiting |
| Universitätsklinikum Halle (Saale) Universitätsklinik und Poliklinik für Innere Medizin I | Halle, Germany | Recruiting |
| Universitätsklinikum Heidelberg, RadioOnkologie & Strahlentherapie | Heidelberg, Germany | Recruiting |
| St. Elisabeth Gruppe GmbH, St. Anna Hospital Herne | Herne, Germany | Recruiting |
+ 10 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05713838